HMGA2 and nasopharyngeal carcinoma: To further determine whether circulating HMGA2 in NPC patients is functionally active in regulating endothelial cells, we treated HUVECs with exosomes from serum of a healthy donor (low HMGA2) or NPC patients with (high HMGA2) and without metastasis (moderate HMGA2).